Sana Biotechnology

company

About

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

  • 101 - 250

Details

Last Funding Type
Seed
Industries
Biotechnology,Health Care,Life Science,Product Research
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients.

Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases.

The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$700M
Sana Biotechnology has raised a total of $700M in funding over 2 rounds. Their latest funding was raised on Jun 23, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 23, 2020 Series A $700M 1 Detail
Jan 1, 2019 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sana Biotechnology is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series A